Moderna Inc. buy Royal Bank of Canada
Start price
28.03.24
/
50%
€98.67
Target price
28.03.25
€115.68
Performance (%)
-37.52%
Price
13.09.24
€61.65
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Moderna Inc. is performing very badly with a performance of -37.52%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Moderna Inc. | -6.250% | -6.250% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Ratings data for MRNA provided by MarketBeat